Table 1.
Demographic and Baseline Characteristics of Patients With Polypoidal Choroidal Vasculopathy and Normal Controls
| Baseline Patients Demographics | |||
|---|---|---|---|
| Polypoidal Choroidal Vasculopathy | Control | ||
| Parameters | (n = 58 Patients, 65 Eyes) | (n = 43 Patients, 43 Eyes) | P Value |
| Age (years) | 68.32 ± 9.20 | 64.65 ± 10.78 | 0.061* |
| Male/female | 44 (67.7%)/21 (32.3%) | 22 (51.2%)/21 (48.8%) | 0.085† |
| Affected eye (OD/OS) | 32 (49.2%)/33 (50.8%) | 18 (41.9%)/25 (58.1%) | 0.452† |
| Spherical equivalent (diopter) | 0.28 ± 1.60 | 0.24 ± 0.97 | 0.564 |
| Subfoveal choroidal thickness (µm) | 428.22 ± 71.08 | 253.35 ± 60.53 | <0.001* |
| Central retinal thickness (µm) | 354.77 ± 129.44 | 247.16 ± 60.80 | <0.001* |
| Area of choroidal hyperpermeability (mm2) | 20.97 ± 13.91 | 7.40 ± 6.72 | <0.001* |
| Area of choroidal hyperpermeability of fellow eye (mm2) | 9.65 ± 6.64 | ||
| Greatest linear dimension (µm) | 2686 ± 906 | ||
| Polyp number | 1.65 ± 0.74 | ||
| Quadrants with one or more engorged vortex veins | <0.001† | ||
| 0 quadrants | 0 | 18 (42%) | |
| 1 quadrants | 0 | 25 (58%) | |
| 2 quadrants | 7 (11%) | 0 (0%) | |
| 3 quadrants | 37 (57%) | 0 (0%) | |
| 4 quadrants | 21 (32%) | 0 (0%) | |
| Quadrants with one or more extended engorged vortex vein | <0.001† | ||
| 0 quadrants | 0 (0%) | 34 (79%) | |
| 1 quadrants | 11 (17%) | 9 (21%) | |
| 2 quadrants | 44 (68%) | 0 (0%) | |
| 3 quadrants | 10 (15%) | 0 (0%) | |
| 4 quadrants | 0 (0%) | 0 (0%) | |
Values are presented as mean ± SD unless indicated otherwise.
*
Student t-test.
†
χ2 test.